• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Microbiome Times

Editor's Choice

Rebiotix and Ferring announce world’s first with positive preliminary pivotal Phase 3 data for investigational microbiome-based therapy

May 6, 2020 Microbiome Times

Today, Rebiotix and Ferring Pharmaceuticals announced positive preliminary findings from their ongoing pivotal Phase 3 trial of the investigational microbiome-based treatment, RBX2660. These preliminary positive efficacy findings mark an important milestone, advancing RBX2660 in its […]

Finance

Chr. Hansen acquires HSO Health Care to grow probiotics offering for women’s health

April 23, 2020 Microbiome Times

Chr. Hansen Holding A/S and HSO Health Care GmbH today entered into an agreement, under which Chr. Hansen will acquire HSO Health Care. The acquisition of the Austria-based B2B company specializing in probiotics for women’s […]

Pharma & Human Health

Quadram Institute part of consortium using new vaccine delivery systems & synthetic biology to tackle coronavirus

April 10, 2020 Microbiome Times

Eastern Arc researchers at the University of East Anglia based in the Quadram Institute and the School of Biosciences at the University of Kent are working to help generate a vaccine against coronavirus and providing […]

Finance

Lodo Therapeutics Achieves Preclinical Milestone In Strategic Collaboration with Genentech

April 9, 2020 Microbiome Times

Lodo Therapeutics Corp., a biotechnology company applying its proprietary platform to reinvent natural product drug discovery, today announced it has achieved a preclinical milestone in its multi-target strategic collaboration with Genentech, a member of the […]

Pharma & Human Health

OxThera announces completion of recruitment in Phase 3 ePHex study with Oxabact® in patients with primary hyperoxaluria

April 8, 2020 Microbiome Times

OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announced today that it has completed enrollment in its Oxabact ePHex phase III study. Oxabact is an investigational […]

Finance

Gilead Sciences & Second Genome Announce Strategic Collaboration in Biomarker and IBD Drug Discovery

April 7, 2020 Microbiome Times

Gilead Sciences, Inc. (Nasdaq: GILD) and Second Genome, a leader in microbiome science, today announced that the companies have entered into a four-year strategic collaboration to identify biomarkers associated with clinical response in up to […]

Pharma & Human Health

Microbiome search engine can increase efficiency in disease detection and diagnosis

April 7, 2020 Microbiome Times

Big data makes big promises when it comes to providing insights into human behavior and health. The problem is how to harness the information it provides in an efficient manner. An international team of researchers […]

Editor's Choice

A common gut microbe secretes a carcinogen

April 4, 2020 Microbiome Times

Cancer mutations can be caused by common gut bacteria carried by many people. This was demonstrated by researchers from the Hubrecht Institute (KNAW) and Princess Máxima Center in Utrecht, the Netherlands. By exposing cultured human […]

Phytobiome & Environment

Scientists seek to establish community-driven metadata standards for microbiomes research

April 4, 2020 Microbiome Times

“We are living through an explosion in the availability of microbiome data,” according to JP Dundore-Arias, assistant professor of plant pathology at California State University, Monterey Bay. “In agricultural systems, the proliferation of research on […]

Pharma & Human Health

Allergan and Bausch Health Identified as the Top Companies Driving Therapeutic Innovation in IBS

April 3, 2020 Microbiome Times

In an ongoing series of research conducted by KMK Consulting, Inc. covering Innovation & Customer Value, Allergan and Bausch Health (backed by its Salix division) were ranked as the top companies best poised to deliver […]

Pharma & Human Health

Persephone Biosciences Announces AI-Driven Microbiome Therapeutic and Diagnostic Programs for COVID-19

April 3, 2020 Microbiome Times

Persephone Biosciences Inc., a biotechnology company that designs microbiome therapeutics and diagnostics to promote normal immune function in order to prevent and fight disease, today announced that it is developing an immune-boosting microbiome therapeutic to […]

Posts navigation

« 1 … 41 42 43 … 78 »

Sign Up to Free Newsletter

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
    November 17, 2025
  • The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
    November 12, 2025
  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
sign up

Sign up to the Microbiome Times newsletter